SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-009510
Filing Date
2022-05-12
Accepted
2022-05-12 10:39:11
Documents
14
Period of Report
2022-05-12
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K imgo-20220512.htm   iXBRL 8-K 58792
2 EX-99.1 imgo-ex99_1.htm EX-99.1 21460
3 GRAPHIC img230188249_0.jpg GRAPHIC 7947
  Complete submission text file 0000950170-22-009510.txt   218047

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imgo-20220512_pre.xml EX-101.PRE 11459
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imgo-20220512.xsd EX-101.SCH 2478
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imgo-20220512_lab.xml EX-101.LAB 13996
8 EXTRACTED XBRL INSTANCE DOCUMENT imgo-20220512_htm.xml XML 4903
Mailing Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 94080 (415) 529-5055
Imago BioSciences, Inc. (Filer) CIK: 0001623715 (see all company filings)

IRS No.: 454915810 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40604 | Film No.: 22916342
SIC: 2834 Pharmaceutical Preparations